Letter by Angiolillo et al Regarding Article, 'Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial'

Autor:	Gregg W. Stone, Dominick J. Angiolillo, Deepak L. Bhatt
Rok vydání:	2021
Předmět:	medicine.medical_specialty Prasugrel business.industry Tirofiban medicine.disease chemistry.chemical_compound Cangrelor chemistry Physiology (medical) Internal medicine medicine Cardiology ST segment In patient Myocardial infarction Cardiology and Cardiovascular Medicine business medicine.drug
Zdroj:	Circulation. 143
ISSN:	1524-4539 0009-7322
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d3931c0717f04abcb56a8e82ac57ef2c https://doi.org/10.1161/circulationaha.120.050205 Zobrazit plný text záznamu